沙美特罗替卡松干粉吸入剂治疗咳嗽变异性哮喘的疗效观察

目的观察沙美特罗替卡松干粉（舒利迭）吸入剂治疗咳嗽变异性哮喘（cough variant asthma,CVA）患者的临床疗效。方法 32例CVA给予舒利迭（沙美特罗/替卡松50μg/250μg）吸入治疗8周后的咳嗽变化情况及肺功能改善情况。结果患者咳嗽严重程度持续下降,症状改善迅速,昼夜呼气峰值流速变异率≤20%,差异有统计学意义（P〈0.05）。结论舒利迭吸入剂可快速有效改善CVA患者症状,应用方便安全。

Curative effect observation of Salmeterol and Fluticasone Propionate dry powder inhaler Treatment of cough variant asthma

Objective To observe the powder salmeterol and fluticasone propionate （Seretide） inhaler treatment of cough variant asthma （cough variant asthma,CVA） in patients with clinical efficacy. Methods 32 patients with CVA were treaded with Seretide （salmeterol/fluticasone 50μg /250μg） after 8 weeks treatment of inhalation cough and pulmonary function changes to improve the situation. The results continued to decline in patients with cough severity,the symptoms improved rapidly,day and night peak expiratory flow rate variation ≤ 20% ,the difference was statistically significant （P 0.05） . Conclusion Seretide inhaler can be quickly and effectively improve symptoms in patients with CVA,convenient and safe applications.